|
Purpose Despite the established role of imatinib (IM) in chronic myelogenous leukemia (CML) in adults, there are few reports on its efficacy in children. In this study, we compared the outcomes of children with CML before and after the advent of IM-based treatment. MethodsThe study cohort consisted of 52 patients treated for CML at the Department of Pediatrics, The Catholic University of... |
